CENP-H can promote CRC progression and modulate response to rapamycin by inhibiting the mechanistic target of rapamycin (mTOR) signaling pathway through interaction with Golgi phosphoprotein 3 (GOLPH3) (25). The gene discussed is GOLPH3; the disease is colorectal carcinoma.